Partner

Dr. Holger Wiemann

Ph. Economics, Cologne, Munich, Paris.Over 25 years in media, digital, internet, software, and health. More than 10 years of tech investments, board positions, consulting & restructuring, national & cross-border M&A. Managing Director and CEO of London, Paris, Corporate P&L responsibility exceeding 3-digit Mill. EUR

Industry experience:

Education and training, healthcare, information technology, media, printing, and publishing.

Leader of Healthcare, Biotech & Pharma Industry Group.

Partner

Neil Mitchell

Chartered Accountant. Joined Rickitt Mitchell in 2004, after four years at PwC and previously at GlaxoSmithKline. Advised on deals from £10m to £150m. Significant experience in buy-side, sell-side, private equity, and IPO mandates across many sectors.

Industry experience:

Aerospace & defence; Beverages; Building & Construction; Engineering; Financial services; Food; Healthcare; Life sciences; Textile & clothing; Transport & logistics.

Co-leader in the Healthcare and Member of the Agri, Food & Beverages Industry Groups. 

Analyst

Lina Benchekroun

Currently a 4th year BBA student at ESADE in Barcelona, Lina is completing an internship at ArsCorporate as an M&A Analyst. During my studies at ESADE, she had the opportunity to be the Marketing Director of Ennova, the largest ESADE association. Moreover, she had the chance to do two internships in consultancy, one at NTT Data and one at PwC.

Managing Partner

Cigdem Bicik

Before founding Crossborder in 2006 Çiğdem worked in the Development and investment banking business for 17 years. She holds an MSc from Loughborough University a BA and MBA in Finance from Istanbul University and is a graduate of the German Gymnasium in Istanbul. She speaks fluent English and German.

Industry experience:

Aerospace & defense; Agriculture; Automotive; Building & construction; Business services; Chemicals; Education and training; Electronics; Energy & renewables; Engineering; Financial services; Food; Government; Hotels & restaurants; Information technology;  Luxury goods; Media, printing, and publishing; Plastics; Real estate & facility management; Retail and franchising; Steel, metal, and woodworking; Telecom; Textile & clothing; Trade; Transport & logistics.

Member of Healthcare Biotech & Pharma Industry Group.

Partner

Didier Busquet

30 years’ experience in M&A and financial engineering. Over 100 missions completed. Retail, services, healthcare and impact investing specialist.
Prior to his M&A activities, he started his career working for a IT firm in Geneva (IT sales & teaching), then Milano (management control), and financial audit in Paris.
Didier co-founded the French M&A consultancy firms network MBA Capital, then M&A Worldwide.
Education: business school – major audit & management control)
Work experience: Software sale, integration and users training /Management control / Financial audit / M&A and financing operations advisory
Other activities: Co-founder of M&A Worldwide, 92 Entreprendre (financing start-ups), and France Angels (Business Angels’ Association)
Board member of the M&A Worldwide network
Member of the investment comitee of Ascendi (impact investing)

Member of the Healthcare, Biotech & Pharma Industry Group

Industry experience:

Business services; Education and training; Information Technology; Retail and franchising.

Managing Partner

Laurent Choppe

Laurent leads Cukierman & Co. Life Sciences since 2008 and has been involved in more than 100 Medtech and Biotech corporate finance transactions and advisory assignments for the Cukierman group. His team works worldwide with venture-backed and middle-market companies for fundraising, licensing deals and M&A transactions as well as strategic projects for key life sciences industry players.

Laurent brings extensive international life sciences experience in managing multifunctional teams and setting up new businesses in pharmaceuticals, medical devices, biotechnology, nutraceuticals, animal health and direct-to-consumer markets.

Member of Healthcare, Biotech & Pharma Industry Group

Director - Strasbourg

Bertrand Dufay

HSBC Global Banking and Markets: Corporate Coverage for Large Caps (CAC 40 or private groups) with a focus on Automotive (Renault / Michelin) and Healthcare (Sanofi / Servier).BNP Paribas Germany (Corporate & Investment Banking): Corporate Coverage on Mid Caps (Mittelstand)/Emerging Markets.

Industry experience:

Automotive; Healthcare.

Member of Healthcare, Biotech & Pharma Industry Group. 

Director

Martin Gray

Skilled in mergers and acquisitions, business disposals, finance raisings, project finance, independent expert reports, valuations, and due diligence, with substantial listed and private company lead advisory experience. Martin has over 20 years of corporate finance experience in Asia, New Zealand and Europe.

Industry experience:

Agriculture; Beverages; Education and training; Food; Healthcare.

Member of the Healthcare, Biotech & Pharma Industry Group.

Managing Director

Alan Kelly

Alan has 25 years’ experience working in start-ups, SMEs and multi-million euro organisations.
Having started his career at Deloitte, Alan then worked as FC of KWE Ireland, a Japanese Logistics Company specialising in services to the Pharmaceutical and Electronics Industries. Alan was appointed General Manager of KWE Ireland in 2003 and oversaw revenue growth from €12m to €20m in 2.5 years.
Alan then joined Fonua, Europe’s largest mobile phone distributor as Commercial Director with responsibility for Operations, Finance & Business Development.
Since 2016, Alan has been a Director of FOCUS Capital Partners and has led a number of equity fundraising projects in multiple sectors.
He currently heads up the M&A Department and has successfully completed transactions (sell side & buy side) in multiple sectors including technology, software, healthcare, manufacturing & distribution.
Alan is an active member of M&A Worldwide and is a co-leader of the Healthcare Industry Group.

Member of the Healthcare, Biotech & Pharma Industry Group. 

Industry experience:

Business services; Clean technology; Education and training; Electronics; Energy & renewables; Healthcare; Information technology; Telecom; Transport & logistics.

Partner

Maurice Koopmans

Experience in M&A for more than 10 years. Involved in 100+ mid-corporate national and international valuations and deals. Industry expertise in Healthcare. ADR-specialist (mediation & negotiation).

Member of Healthcare, Biotech & Pharma Industry Group.

Industry experience:

Business services; Education and training; Government; Healthcare; Life sciences; Media, printing, and publishing; Real estate & facility management; Recycling; Security; Trade; Wholesale.

Vice President

Agustin Magliola

 Vice President at Finanzas & Gestión since 2017. Mr. Magliola holds a Bachelor’s degree in Business Administration and a CPA degree from Universidad de San Andrés. Prior to joining Finanzas & Gestión, Mr. Magliola worked at Lazard and at Grupo Bimbo.

Industry experience:

Agriculture; Automotive; Beverages; Building & construction; Chemicals; Energy & renewables; Financial services; Food; Healthcare; Hotels & restaurants; Plastics; Real estate & facility management; Recycling; Retail and franchising; Security; Steel, metal and wood working; Telecom; Textile & clothing; Transport & logistics; Wholesale.

Member of the Healthcare Industry Group.

Associate

Igor Neumann

• Strategic company and market analysis
• Stakeholder management throughout the M&A process, coordination of internal and external expert teams
• Organisation and execution of due diligence, data room and other transaction services.

Member of the Healthcare, Biotech & Pharma Industry Group.

Partner

Eduardo Gómez de la Torre

Over 27 years of experience in Investment Banking and Corporate Finance. Before joining Misti Capital, he held different positions in Credicorp Group, including BCP’s Corporate and International Banking Division Manager and Regional Head of the Investment Banking team of Credicorp Capital. He has led hundreds of corporate financings, as well as M&A transactions and capital market issuances. He built the Investment Banking team at Scotiabank Peru and he previously worked in the Investment Banking team at Deutsche Bank in New York.

Industry experience:

Beverages; Education and training; Energy & renewables; Financial services; Steel, metal and wood working.

Member of the Consumer & Retail, Energy Environment & Cleanch and the Healthcare, Biotech & Pharma Industry Groups.

Managing Director

Eric Yetter

Investment banker focused on healthcare. His practice includes healthcare services, outsourced services, medical devices, and healthcare IT. Has completed a variety of healthcare transactions, many with private equity firms and PE-backed companies. His past clients include leading physician groups, healthcare facilities, and institutional healthcare investors.

Founded Physicians First in 2016, recognizing the emerging need for investment banking and advisory services for owners of physician practices, surgery centers and clinical businesses. The next four years saw record levels of physician-owner M&A activity and Physicians First became one of the nation’s most active advisors for transactions between private equity firms and medical practices. In 2021, Eric Yetter agreed to merge Physicians First with FOCUS and lead the firm’s healthcare team.

Also has healthcare operating and investing experience. He was an early executive at Covenant Physician Partners (previously Covenant Surgical Partners), an acquirer and operator of ambulatory surgery centers and physician practices. The company built and operated an outsourced laboratory, an anesthesia business, and a revenue cycle management company. Covenant has grown into a major player in healthcare services and is currently backed by private equity firm KKR.

Prior to Covenant, Eric held operating roles at Volkswagen Group of America and Brainlab, Inc., an image-guided surgery company. While at Brainlab, worked with leading neurosurgeons and hospitals to implement cutting edge technology and improve patient outcomes.

He is a licensed attorney (currently inactive) and earned JD and BS degrees from Vanderbilt University, graduating with high honours; and a FINRA licensed investment banker.

Member of Healthcare, Biotech & Pharma Industry Group.